Skip to content

A study to assess Efficacy and safety of Ayurvedic Kadha in health and immunity related parameters in mild COVID-19 patients.

A Prospective, Single center, single arm study to Evaluate Efficacy and safety of Ayurvedic Kadha in health and immunity related parameters in mild COVID-19 patients. - Kadha

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/03/032072
Enrollment
50
Registered
2021-03-17
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

Intervention1: Ayurvedic Kadha: 2 Drops into 150 ml of water to be taken twice a day for 7 days Control Intervention1: NIL: NIL

Sponsors

MARC Laboratories Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age > 18 years 2. Written Informed consent is documented 3. COVID-19 positive clinical symptoms and (subsequently) confirmed by the current recommended confirmatory test (RT PCR). 4. Can take oral medicines. 5. Mild-moderate grade of the disease.

Exclusion criteria

Exclusion criteria: 1. Known sensitivity to any of the ingredients 2. Bleeding haemorrhoids 3. Serious stages of the illnesses 4. ICU admitted patients 5. Pre-existing GI symptoms like nausea or vomiting

Design outcomes

Primary

MeasureTime frame
Clinical status as assessed with the seven-category ordinal scale on days 7 and 14Timepoint: Day1, Day 7 and Day14

Secondary

MeasureTime frame
1. Laboratory parameters for Serum C - reactive protein (CRP, Hb, Total leukocyte count and differential leukocyte count. 2.Fever to normal temperature in days. 3.Time to negative PCR days. 4. Change in LFT ParametersTimepoint: Day1 and Day14

Countries

India

Contacts

Public ContactDr Devesh Kumar

IR Innovate Research Pvt. Ltd.

devesh.kumar@innovate-research.com9971169602

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026